abstract |
Novel processes for the preparation of a compound of Formula I-2 substantially free of the 5,6-trans isomer: n nwhereinn n nR 2 , R 3 and R 4 are as defined in the specification are provided. Novel intermediates for the preparations of isomer free Prostaglandins and derivatives thereof are also provided. |